Evidence map›Paper›PMID 40376440›Full record

ReviewEXCLI journal2025

p-Synephrine: an overview of physicochemical properties, toxicity, biological and pharmacological activity.

Maciej Kulawik, Kaja Bajewska, Anna Kulawik

Abstract readReview
In one paragraph

Review in EXCLI journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maciej KulawikPoznan University of Medical Sciences, Fredry 10 St., 61-701 Poznan, Poland.
Kaja BajewskaPoznan University of Medical Sciences, Fredry 10 St., 61-701 Poznan, Poland.
Anna KulawikDoctoral School, Poznan University of Medical Sciences, Bukowska 70 St., 60-812 Poznan, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

p-Synephrine is a popular ingredient in dietary supplements. It is also found in trace amounts in living organisms. It is advertised as a weight loss supplement and it is supposed to improve performance in sports. It is contained in plants of the Citrus family, making it widespread in the human diet. Its pharmacological properties include effects on multiple receptors and signaling pathways. Its effects on the alpha and betanergic systems promote doubts about its safety. There are many studies describing a lack of concern when it comes to the potential harmful effects of this compound. On the other hand, several health incidents associated with p-synephrine use have been reported in the scientific literature, making the toxicity of this compound unclear. This review aims to organize the current knowledge about p-synephrine, including physicochemical characteristics, sources of occurrence, pharmacological effects and possible toxic effects. In addition, the presence of three substitution isomers of the hydroxyl group and one chiral carbon atom causes confusion in the literature. Studies conducted on the short-term use of p-synephrine do not indicate its toxicity at low doses for healthy people. Further studies are needed to determine its long-term safety and possible interactions with other chemical compounds. See also the graphical abstract(Fig. 1).

Indexed as

Citrus speciesdietary supplementsphytochemicalsp-synephrine

Identifiers

PMID40376440
PMCPMC12078783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.